CytomX Therapeutics (CTMX) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to $1.6 million.
- CytomX Therapeutics' Interest & Investment Income fell 596.57% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 4016.27%. This contributed to the annual value of $7.1 million for FY2024, which is 2745.76% down from last year.
- CytomX Therapeutics' Interest & Investment Income amounted to $1.6 million in Q3 2025, which was down 596.57% from $1.2 million recorded in Q2 2025.
- Over the past 5 years, CytomX Therapeutics' Interest & Investment Income peaked at $2.7 million during Q3 2023, and registered a low of $44000.0 during Q2 2021.
- In the last 5 years, CytomX Therapeutics' Interest & Investment Income had a median value of $1.2 million in 2025 and averaged $1.2 million.
- In the last 5 years, CytomX Therapeutics' Interest & Investment Income plummeted by 9367.44% in 2021 and then skyrocketed by 332205.88% in 2023.
- CytomX Therapeutics' Interest & Investment Income (Quarter) stood at $73000.0 in 2021, then soared by 902.74% to $732000.0 in 2022, then surged by 241.94% to $2.5 million in 2023, then plummeted by 48.94% to $1.3 million in 2024, then grew by 24.57% to $1.6 million in 2025.
- Its last three reported values are $1.6 million in Q3 2025, $1.2 million for Q2 2025, and $955000.0 during Q1 2025.